Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial update evaluating upfront chemotherapy with bevacizumab in advanced ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients [Phase 1]
Phase 1 study evaluating docetaxel in combination with PTK787 in metastatic breast cancer and gynecologic cancers; the trial conducted by Da…
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function
This clinical trial update summarizes completed findings on fertility issues and sexual function in young women diagnosed with early-stage o…
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer
The document outlines a clinical trial evaluating the role of HE4 as a follow-up biomarker for advanced ovarian, fallopian tube, and primary…
-
FDA approval · 2018-07-20FDA Approved: GEMCITABINE — Original Application (Sagent Pharmaceuticals)
FDA approves Sagent Pharmaceuticals' original ANDA for gemcitabine, a generic injectable chemotherapy used to treat several cancers.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma [Phase 2]
A Phase 2 clinical trial update for sunitinib in patients with recurrent ovarian clear cell carcinoma has completed.
-
CLINICAL_TRIALS research · 2018-07-11Clinical Trial Update: PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers. [Phase 1]
A Phase 1 clinical trial evaluating PD-L1 inhibition combined with focal radiotherapy in recurrent ovarian, primary peritoneal, and fallopia…
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors [Phase 1]
Phase 1 study of nintedanib plus bevacizumab in advanced solid tumors has completed, assessing safety and preliminary activity across severa…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer [Phase 2]
A Phase 2 trial of CRLX101 in combination with Bevacizumab for recurrent ovarian, fallopian tube, or primary peritoneal cancer has completed…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) [Phase 1, Phase 2]
A Phase 1/2 trial of pembrolizumab plus chemotherapy in patients with various advanced cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-06-29Clinical Trial Update: Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy [Phase 1]
This Phase 1 study of veliparib in patients with malignant solid tumors that did not respond to prior therapy has completed.
-
CLINICAL_TRIALS research · 2018-06-28Clinical Trial Update: BRCA Main Home Nutritional Intervention-random Study [NA]
Clinical trial update for a BRCA mutation-related nutritional intervention; no status or results provided.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy [Phase 2]
A Phase 2 trial assessing the safety and efficacy of Quisinostat in combination with chemotherapy for ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-21Clinical Trial Update: A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of DMUC4064A in platinum-resistant ovarian cancer and unresectable pancreatic cance…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants [Phase 1, Phase 2]
This document summarizes a completed Phase 1/2 clinical trial evaluating antioxidants as treatment for newly diagnosed ovarian cancer.
-
CLINICAL_TRIALS withdrawal · 2018-06-15Clinical Trial Update: An Exercise Intervention Trial to Reduce Symptoms & Improve Clinical Outcomes of Platinum-Based Treatment in Ovarian Cancer Patients [NA]
A clinical trial evaluating an exercise intervention to reduce symptoms and improve outcomes for ovarian cancer patients receiving platinum-…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib [Phase 2]
This Phase 2 trial evaluated cediranib in combination with olaparib for ovarian cancer and has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Autologous OC-DC Vaccine in Ovarian Cancer [EARLY_Phase 1]
A Phase 1 study of an autologous OC-DC dendritic cell vaccine in ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer [Phase 2]
Phase 2 trial in ovarian cancer comparing ABT-888 (veliparib) in combination with temozolomide versus pegylated liposomal doxorubicin has co…
-
CLINICAL_TRIALS withdrawal · 2018-06-06Clinical Trial Update: PET Imaging of Ovarian Carcinoma With 18F-FSPG [EARLY_Phase 1]
A Phase 1 trial evaluating the PET imaging agent 18F-FSPG for ovarian, fallopian tube, and primary peritoneal cancers has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating apatinib for advanced ovarian cancer after failure of standard chemotherapy.
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer [Phase 2]
Phase 2 trial update of alisertib (MLN8237) in ovarian, fallopian tube, or peritoneal cancer following a prior MLN8237 plus paclitaxel Phase…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: EC17 for Intraoperative Imaging in Occult Ovarian Cancer [Phase 1]
A Phase 1 clinical trial evaluating EC17 as an intraoperative imaging agent for detecting occult ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer [Phase 2]
Clinical trial update noting the completion of a Phase 2 study evaluating a psychosexual intervention in patients with Stage I-III gynecolog…
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating pembrolizumab (Keytruda) plus chemotherapy versus chemotherapy alone in recurrent platinum-resistant ovarian canc…